According to our (Global Info Research) latest study, the global Metformin Hydrochloride market size was valued at US$ 459 million in 2025 and is forecast to a readjusted size of US$ 662 million by 2032 with a CAGR of 5.4% during review period.
Metformin hydrochloride is the raw material of finished product metformin hydrochloride drugs. That is the API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5·HCL and a molecular weight of 165.63. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether and chloroform. In this report, our statistics is given by metformin hydrochloride API.In 2025, global Metformin Hydrochloride reached approximately 78.4 K MT.
The Metformin Hydrochloride market is primarily driven by the sustained increase in the global prevalence of type 2 diabetes and the continued importance of metformin as a first-line glucose-lowering therapy. Population aging, urbanization, sedentary lifestyles, obesity, and changing dietary patterns are contributing to a growing population requiring long-term diabetes management, particularly in China, India, Southeast Asia, the Middle East, Latin America, and other emerging markets. Metformin Hydrochloride has a well-established efficacy and safety profile, extensive clinical experience, and relatively low treatment cost, allowing it to remain one of the most widely prescribed oral antidiabetic drugs. Its inclusion in treatment guidelines and essential-medicine systems across numerous countries provides a stable underlying demand base for both active pharmaceutical ingredient manufacturers and finished-dosage producers.
Another major driver is the expanding use of Metformin Hydrochloride in combination therapies. Diabetes treatment is increasingly shifting toward individualized multi-drug regimens, and metformin is frequently combined with DPP-4 inhibitors, SGLT2 inhibitors, sulfonylureas, thiazolidinediones, and other glucose-lowering agents when monotherapy is insufficient. Fixed-dose combination products improve treatment convenience and can support patient adherence, creating additional demand beyond conventional metformin tablets. Although newer drug classes such as GLP-1 receptor agonists and SGLT2 inhibitors are gaining importance, they generally complement rather than eliminate metformin use for a substantial proportion of patients, particularly where affordability, broad accessibility, and long-term clinical familiarity remain important considerations.
The market is also supported by the large global generic-drug industry and continued expansion of pharmaceutical manufacturing capacity in cost-competitive regions. Metformin Hydrochloride is a mature, high-volume API with broad demand from generic pharmaceutical companies, making manufacturing efficiency, regulatory compliance, impurity control, supply reliability, and competitive pricing important purchasing considerations. Growing access to diabetes diagnosis and treatment in developing economies, expansion of public healthcare and reimbursement programs, and increasing penetration of affordable generic medicines are further enlarging the addressable patient population. At the same time, stricter pharmaceutical quality standards are encouraging downstream manufacturers to establish more stable relationships with qualified API suppliers, benefiting producers capable of maintaining consistent product quality, regulatory documentation, and large-scale supply.
Report Scope
This report is a detailed and comprehensive analysis for global Metformin Hydrochloride market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Metformin Hydrochloride market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/MT), 2021-2032
Global Metformin Hydrochloride market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/MT), 2021-2032
Global Metformin Hydrochloride market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/MT), 2021-2032
Global Metformin Hydrochloride market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (US$/MT), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Metformin Hydrochloride
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Metformin Hydrochloride market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include POSCO M-Tech, Nippon Kinzoku, SEIKI, Komazawa Metal Industry, Daiwa Metal, PJ Metal, Superior Aluminum Alloys, Arfin India Limited, Vega Alloys, BN Industries, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Metformin Hydrochloride market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market Segmentation
Market segment by Type
Metformin HCL
Metformin DC
Market segment by Feature
Standard Grade Metformin Hydrochloride
Special Grade Metformin Hydrochloride
Market segment by Channel
Direct Sales
Distribution
Market segment by Application
Metformin Hydrochloride Tablets
Metformin Hydrochloride Extended-Release Tablets
Major players covered
POSCO M-Tech
Nippon Kinzoku
SEIKI
Komazawa Metal Industry
Daiwa Metal
PJ Metal
Superior Aluminum Alloys
Arfin India Limited
Vega Alloys
BN Industries
Yunnan Jiangnan Hongsheng New Materials
Luoyang Sanwu Cable Group
Gongyi Jintai Metallurgical Materials
Hubei Guoxin Aluminum
Holingol Lifeng Aluminum
LCE-alloy
Anyang Hongxin
Gongyi Yalv Materials
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Metformin Hydrochloride product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Metformin Hydrochloride, with price, sales quantity, revenue, and global market share of Metformin Hydrochloride from 2021 to 2026.
Chapter 3, the Metformin Hydrochloride competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Metformin Hydrochloride breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Metformin Hydrochloride market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Metformin Hydrochloride.
Chapter 14 and 15, to describe Metformin Hydrochloride sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on POSCO M-Tech
Nippon Kinzoku
SEIKI
Komazawa Metal Industry
Daiwa Metal
PJ Metal
Superior Aluminum Alloys
Arfin India Limited
Vega Alloys
BN Industries
Yunnan Jiangnan Hongsheng New Materials
Luoyang Sanwu Cable Group
Gongyi Ji. Industry analysis & Market Report on POSCO M-Tech
Nippon Kinzoku
SEIKI
Komazawa Metal Industry
Daiwa Metal
PJ Metal
Superior Aluminum Alloys
Arfin India Limited
Vega Alloys
BN Industries
Yunnan Jiangnan Hongsheng New Materials
Luoyang Sanwu Cable Group
Gongyi Ji is a syndicated market report, published as Global Metformin Hydrochloride Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of POSCO M-Tech
Nippon Kinzoku
SEIKI
Komazawa Metal Industry
Daiwa Metal
PJ Metal
Superior Aluminum Alloys
Arfin India Limited
Vega Alloys
BN Industries
Yunnan Jiangnan Hongsheng New Materials
Luoyang Sanwu Cable Group
Gongyi Ji market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.